Rao S - Search Results

1

Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer.

Woolston A, Barber LJ, Griffiths B, Pich O, Lopez-Bigas N, Matthews N, Rao S, Watkins D, Chau I, Starling N, Cunningham D, Gerlinger M. Woolston A, et al. Among authors: rao s. Nat Ecol Evol. 2021 Jul;5(7):1024-1032. doi: 10.1038/s41559-021-01470-8. Epub 2021 May 20. Nat Ecol Evol. 2021. PMID: 34017094 Free PMC article.

2

Chemotherapy of oesophago-gastric cancer.

Ross PJ, Rao S, Cunningham D. Ross PJ, et al. Among authors: rao s. Pathol Oncol Res. 1998;4(2):87-95. doi: 10.1007/BF02904700. Pathol Oncol Res. 1998. PMID: 9654592 Free article. Review.

3

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.

Waters JS, Norman A, Cunningham D, Scarffe JH, Webb A, Harper P, Joffe JK, Mackean M, Mansi J, Leahy M, Hill A, Oates J, Rao S, Nicolson M, Hickish T. Waters JS, et al. Among authors: rao s. Br J Cancer. 1999 Apr;80(1-2):269-72. doi: 10.1038/sj.bjc.6690350. Br J Cancer. 1999. PMID: 10390007 Free PMC article. Clinical Trial.

4

An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.

Chau I, Webb A, Cunningham D, Hill M, Rao S, Ageli S, Norman A, Gill K, Howard A, Catovsky D. Chau I, et al. Among authors: rao s. Br J Haematol. 2001 Dec;115(4):786-92. doi: 10.1046/j.1365-2141.2001.03181.x. Br J Haematol. 2001. PMID: 11843810 Free article. Clinical Trial.

5

Advanced pancreatic cancer--5 years on.

Rao S, Cunningham D. Rao S, et al. Ann Oncol. 2002 Aug;13(8):1165-8. doi: 10.1093/annonc/mdf313. Ann Oncol. 2002. PMID: 12181237 Free article. No abstract available.

6

Adjuvant therapy for colon cancer in the new millenium.

Rao S, Cunningham D. Rao S, et al. Scand J Surg. 2003;92(1):57-64. doi: 10.1177/145749690309200109. Scand J Surg. 2003. PMID: 12705552 Review.

7

Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.

Rao S, Cunningham D, Price T, Hill ME, Ross PJ, Tebbutt N, Norman AR, Oates J, Shellito P. Rao S, et al. Br J Cancer. 2004 Aug 31;91(5):839-43. doi: 10.1038/sj.bjc.6602039. Br J Cancer. 2004. PMID: 15266319 Free PMC article. Clinical Trial.

8

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma.

Rao S, Watkins D, Cunningham D, Dunlop D, Johnson P, Selby P, Hancock BW, Fegan C, Culligan D, Schey S, Morris TC, Lissitchkov T, Oliver JW, Holmlund JT. Rao S, et al. Ann Oncol. 2004 Sep;15(9):1413-8. doi: 10.1093/annonc/mdh359. Ann Oncol. 2004. PMID: 15319248 Free article. Clinical Trial.

9

Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer.

Rao S, Cunningham D, de Gramont A, Scheithauer W, Smakal M, Humblet Y, Kourteva G, Iveson T, Andre T, Dostalova J, Illes A, Belly R, Perez-Ruixo JJ, Park YC, Palmer PA. Rao S, et al. J Clin Oncol. 2004 Oct 1;22(19):3950-7. doi: 10.1200/JCO.2004.10.037. J Clin Oncol. 2004. PMID: 15459217 Clinical Trial.

10

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

Rao S, Cunningham D, Hawkins RE, Hill ME, Smith D, Daniel F, Ross PJ, Oates J, Norman AR. Rao S, et al. Br J Cancer. 2005 May 9;92(9):1650-4. doi: 10.1038/sj.bjc.6602576. Br J Cancer. 2005. PMID: 15856037 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,742 results

Search Page

Filters